STOCK TITAN

[144] ASP Isotopes Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

ASP Isotopes Inc. (ASPI) filed a Form 144 notifying the proposed sale of 75,000 shares of its common stock through Independent Trading Group (ITG) on the NASDAQ with an aggregate market value of $789,750. The filer acquired 200,000 shares as a restricted stock award on August 16, 2023, paid by equity compensation on that date. The approximate date of sale is listed as August 29, 2025. The filing reports no securities sold during the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.

ASP Isotopes Inc. (ASPI) ha presentato un Modulo 144 comunicando la vendita programmata di 75.000 azioni del proprio capitale sociale tramite Independent Trading Group (ITG) sul NASDAQ, per un valore di mercato complessivo di 789.750 USD. Il soggetto cedente aveva ottenuto 200.000 azioni come restricted stock award il 16 agosto 2023, corrisposte come compenso in azioni in quella data. La data approssimativa di vendita è indicata come 29 agosto 2025. La comunicazione segnala che non sono stati venduti titoli nei precedenti tre mesi e include la consueta dichiarazione secondo cui il venditore non è a conoscenza di informazioni materiali non divulgate sull'emittente.

ASP Isotopes Inc. (ASPI) presentó un Formulario 144 notificando la prevista venta de 75.000 acciones de su capital social a través de Independent Trading Group (ITG) en el NASDAQ, con un valor de mercado agregado de 789.750 USD. El declarante adquirió 200.000 acciones como restricted stock award el 16 de agosto de 2023, pagadas como compensación en acciones en esa fecha. La fecha aproximada de venta figura como 29 de agosto de 2025. La presentación informa que no se vendieron valores en los últimos tres meses e incluye la representación estándar de que el vendedor no tiene conocimiento de información material no divulgada sobre el emisor.

ASP Isotopes Inc. (ASPI)는 Form 144를 제출하여 NASDAQ을 통해 Independent Trading Group(ITG)으로 75,000주의 보통주를 총시장가치 $789,750로 매각할 예정임을 통지했습니다. 제출인은 2023년 8월 16일restricted stock award200,000주를 보유하게 되었으며, 해당 일자에 주식 보상으로 지급받았습니다. 예상 매각일은 2025년 8월 29일로 기재되어 있습니다. 신고서에는 지난 3개월 동안 매도한 증권이 없다고 보고되어 있으며, 매도인이 발행회사에 대한 미공개 중대한 불리한 정보를 알고 있지 않다는 표준적인 진술을 포함하고 있습니다.

ASP Isotopes Inc. (ASPI) a déposé un formulaire 144 signalant la vente prévue de 75 000 actions de son capital social via Independent Trading Group (ITG) sur le NASDAQ, pour une valeur de marché totale de 789 750 USD. Le déclarant a acquis 200 000 actions au titre d'une restricted stock award le 16 août 2023, payées comme rémunération en actions à cette date. La date approximative de la vente est indiquée au 29 août 2025. Le dépôt précise qu'aucun titre n'a été vendu au cours des trois derniers mois et inclut la mention standard selon laquelle le vendeur n'a pas connaissance d'informations défavorables matérielles non divulguées concernant l'émetteur.

ASP Isotopes Inc. (ASPI) reichte ein Formular 144 ein und meldete den geplanten Verkauf von 75.000 Aktien seiner Stammaktien über Independent Trading Group (ITG) an der NASDAQ mit einem Gesamtmarktwert von 789.750 USD. Der Meldende hatte am 16. August 2023 200.000 Aktien als restricted stock award erhalten, vergütet durch Aktienvergütung an diesem Datum. Das voraussichtliche Verkaufsdatum ist mit 29. August 2025 angegeben. Die Meldung vermerkt, dass in den vergangenen drei Monaten keine Wertpapiere verkauft wurden, und enthält die übliche Erklärung, dass dem Verkäufer keine nicht offengelegten, wesentlichen nachteiligen Informationen über den Emittenten bekannt sind.

Positive
  • Transparent disclosure of the proposed sale with broker, venue, quantity, and aggregate value
  • Clear acquisition history showing the shares were received as restricted stock award on 08/16/2023
  • No sales in the past three months reported, simplifying aggregation considerations under Rule 144
Negative
  • None.

Insights

TL;DR: Routine Rule 144 notice for a planned sale of restricted shares; transaction size is small relative to outstanding shares.

The filing documents a proposed sale under Rule 144 of 75,000 common shares valued at $789,750 to be executed via ITG on Nasdaq. The shares were originally issued as restricted stock compensation (200,000 shares) on August 16, 2023, and payment was in equity compensation. No sales were reported in the prior three months, which supports Rule 144 aggregation disclosures. Based solely on the filing, this appears to be a compliance disclosure rather than a material corporate event.

TL;DR: Disclosure aligns with required insider sale notifications; includes requisite seller representation about material information.

The Form 144 contains the required seller attestations and transaction details: broker, execution venue, class, quantity, and acquisition provenance (restricted award). It also notes the filer represents no undisclosed material adverse information. The filing provides sufficient procedural detail to satisfy Rule 144 notice requirements but does not present governance changes or new corporate actions.

ASP Isotopes Inc. (ASPI) ha presentato un Modulo 144 comunicando la vendita programmata di 75.000 azioni del proprio capitale sociale tramite Independent Trading Group (ITG) sul NASDAQ, per un valore di mercato complessivo di 789.750 USD. Il soggetto cedente aveva ottenuto 200.000 azioni come restricted stock award il 16 agosto 2023, corrisposte come compenso in azioni in quella data. La data approssimativa di vendita è indicata come 29 agosto 2025. La comunicazione segnala che non sono stati venduti titoli nei precedenti tre mesi e include la consueta dichiarazione secondo cui il venditore non è a conoscenza di informazioni materiali non divulgate sull'emittente.

ASP Isotopes Inc. (ASPI) presentó un Formulario 144 notificando la prevista venta de 75.000 acciones de su capital social a través de Independent Trading Group (ITG) en el NASDAQ, con un valor de mercado agregado de 789.750 USD. El declarante adquirió 200.000 acciones como restricted stock award el 16 de agosto de 2023, pagadas como compensación en acciones en esa fecha. La fecha aproximada de venta figura como 29 de agosto de 2025. La presentación informa que no se vendieron valores en los últimos tres meses e incluye la representación estándar de que el vendedor no tiene conocimiento de información material no divulgada sobre el emisor.

ASP Isotopes Inc. (ASPI)는 Form 144를 제출하여 NASDAQ을 통해 Independent Trading Group(ITG)으로 75,000주의 보통주를 총시장가치 $789,750로 매각할 예정임을 통지했습니다. 제출인은 2023년 8월 16일restricted stock award200,000주를 보유하게 되었으며, 해당 일자에 주식 보상으로 지급받았습니다. 예상 매각일은 2025년 8월 29일로 기재되어 있습니다. 신고서에는 지난 3개월 동안 매도한 증권이 없다고 보고되어 있으며, 매도인이 발행회사에 대한 미공개 중대한 불리한 정보를 알고 있지 않다는 표준적인 진술을 포함하고 있습니다.

ASP Isotopes Inc. (ASPI) a déposé un formulaire 144 signalant la vente prévue de 75 000 actions de son capital social via Independent Trading Group (ITG) sur le NASDAQ, pour une valeur de marché totale de 789 750 USD. Le déclarant a acquis 200 000 actions au titre d'une restricted stock award le 16 août 2023, payées comme rémunération en actions à cette date. La date approximative de la vente est indiquée au 29 août 2025. Le dépôt précise qu'aucun titre n'a été vendu au cours des trois derniers mois et inclut la mention standard selon laquelle le vendeur n'a pas connaissance d'informations défavorables matérielles non divulguées concernant l'émetteur.

ASP Isotopes Inc. (ASPI) reichte ein Formular 144 ein und meldete den geplanten Verkauf von 75.000 Aktien seiner Stammaktien über Independent Trading Group (ITG) an der NASDAQ mit einem Gesamtmarktwert von 789.750 USD. Der Meldende hatte am 16. August 2023 200.000 Aktien als restricted stock award erhalten, vergütet durch Aktienvergütung an diesem Datum. Das voraussichtliche Verkaufsdatum ist mit 29. August 2025 angegeben. Die Meldung vermerkt, dass in den vergangenen drei Monaten keine Wertpapiere verkauft wurden, und enthält die übliche Erklärung, dass dem Verkäufer keine nicht offengelegten, wesentlichen nachteiligen Informationen über den Emittenten bekannt sind.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does ASPI's Form 144 disclose about the planned sale?

The filing discloses a proposed sale of 75,000 common shares via Independent Trading Group on NASDAQ with an aggregate market value of $789,750 and an approximate sale date of 08/29/2025.

How were the shares being sold by ASPI acquired?

The shares were acquired as a restricted stock award from the issuer on 08/16/2023, with 200,000 shares shown as acquired and payment recorded as equity compensation.

Does the Form 144 report any recent sales by the filer?

No; the filing states Nothing to Report for securities sold during the past three months.

Where will the proposed ASPI sale be executed and through which broker?

The sale is planned to be executed on the NASDAQ through Independent Trading Group (ITG), located at the address given in the filing.

What representation does the filer make about material information?

By signing the notice, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.
ASP Isotopes

NASDAQ:ASPI

ASPI Rankings

ASPI Latest News

ASPI Latest SEC Filings

ASPI Stock Data

852.95M
71.24M
22.48%
45.31%
14.41%
Chemicals
Miscellaneous Chemical Products
Link
United States
WASHINGTON